ByteDance's drug unit showed an AI-designed IL-17 inhibitor at a Boston conference. The molecule targets interactions pharma called undruggable. Only trials will tell.

For every life-changing new drug that comes to market, many candidates fail along the way. An artificial intelligence-based ...

Building on a long-standing MIT-IBM collaboration, the new lab will chart the convergence of AI, algorithms, and quantum ...

The following is a joint announcement by the MIT Schwarzman College of Computing and IBM.IBM and MIT today announced the ...

Due to the explosive growth of artificial intelligence, it is estimated that data centers will consume up to 12% of total U.S ...

This article explores how building structured, connected data systems is essential to unlocking reliable insights, ...

Chemists and computer scientists tapped AI to find new disinfectants to combat the growing threat of dangerous "superbugs." ...

From executive shakeups to "Agentic Ready" payments, the industry's biggest players are pivoting to meet the next era of ...

Materials called relaxor ferroelectrics have been used for decades in technologies like ultrasounds, microphones, and sonar ...

For the first time, researchers directly characterized the 3D atomic structure of a relaxor ferroelectric, a class of ...

Million Records Built from Live Attack Traffic Released to Advance Cybersecurity Research at the University of ...

AI can match doctors in diagnostic reasoning, but experts warn rapid progress outpaces safeguards needed for real-world use.